Biocryst Flu Drug Missing From CDC Guidelines: BioBuzz
Investors waiting for government to buy emergency stockpile of peramivir
02:27PM 09/08/09
Spectrum shares fall despite drug approval: BioBuzz
Uncertainty over Zevalin's relaunch likely weighing on stock price
11:18AM 09/08/09
Osiris Stem Cell Drug Fails: BioBuzz
Negative results announced from two phase III studies in graft-versus-host-disease
08:44AM 09/08/09
Cell Therapeutics Gets Standard Review: BioBuzz
FDA appeal denied, cancer drug pixantrone's approval decision date remains April 2010
06:59AM 09/08/09
Merck Spent $1.5M In 2Q Lobbying On Health Reform
Merck spent $1.5 million lobbying on health care reform, other issues in second quarter
12:42PM 08/21/09
Biotech Calendar: Key Clinical Trial Dates
Part 3 in our quick-and-dirty guide to upcoming clinical trial dates for drug and biotech companies.
08:00AM 06/30/09
Merck Spent $1.5M In 1Q Lobbying On Health Reform
Drugmaker Merck spent $1.5 million in first quarter lobbying on health care reform
05:26PM 06/12/09
99 Cents Only Stores, Steris, Stryker and Transatlantic Holdings are upgraded; TFS Financial is downgraded.
05:24PM 06/11/09
Biotech Calendar: Key Clinical Trial Dates
A quick and dirty guide to upcoming clinical trial dates for drug and biotech companies.
11:02AM 06/10/09
Earnings Roundup: URS, Jack In The Box
Earnings roundup: URS 1Q profit beats expectations, Jack in the Box 2Q earnings climb 14 pct
06:31PM 05/13/09
Insmed Swings To 1Q Profit On Merck Deal
Insmed swings to 1st-quarter profit on sale of assets, facility to Merck
03:54PM 05/13/09
Analysts Look For News On Merck Tie-up, Key Drugs
Analysts looking for news on Merck tie-up with Schering-Plough, sales of key drugs in Q1
05:16PM 04/17/09
Dow Watch: Coke Soars, BofA Fights Back
Bank of America and Citigroup rally from their worst levels, while Coca-Cola is the best performer on the Dow Thursday.
05:16PM 02/12/09
Friday's Small-Cap Winners & Losers
Pacer falls on a sharp decline in first-quarter profits.
09:40PM 08/06/07



Connect with TheStreet